ADVERUM BIOTECHNOLOGIES |
USA |
Gesundheit |
US00773U2078 / A404YL |
AVU0 (Frankfurt) / ADVM (NASDAQ) |
FRA:AVU0, ETR:AVU0, AVU0:GR, NASDAQ:ADVM |
- |
https://adverum.com/ |
47.02 Mio. EUR |
0.87 Mio. EUR |
-134.56 Mio. EUR |
-5.449 EUR |
80.97 Mio. EUR |
72.2 Mio. EUR |
- / - |
- / - |
52.91 / 2 / - |
- / -144.51% |
- |
- / - |
- |
ADVERUM |
25.06.25 |
|